BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24763011)

  • 21. Effect of recombinant human thrombopoietin on IL-2, IL-4 and platelet parameters in thrombocytopenic purpura.
    Zhao M; Liang X; Chen C; Du X; Dang X
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):119-125. PubMed ID: 37571891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Treatment of Newly Diagnosed Primary Immune Thrombocytopenia by Recombinant Human Thrombopoietin Combined with Glucocorticoid].
    Yuan J; Li LY; Wang ZZ; Liu XJ; Yang L; Luo JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):832-835. PubMed ID: 35680813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of recombinant human thrombopoietin combined with high-dose dexamethasone in the treatment of refractory immune thrombocytopenia in children].
    Lu YY; Guan N; Meng QH; Li ML; Liu YY; Wang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):534-537. PubMed ID: 30022753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y; Jin G; Sun J; Wang X; Guo L
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: a retrospective study in senile patients.
    Lin J; Zhu H; Li S; Fan H; Lu X
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):19-24. PubMed ID: 23637005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y; Jiang J; Jiao L
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of high-dose dexamethasone combined with rhTPO for newly diagnosed adults with severe immune thrombocytopenia].
    Li Y; Huang Q; Wang C; Muhebaier ; An L; Wang X
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):134-7. PubMed ID: 27333620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
    Angiolillo AL; Davenport V; Bonilla MA; van de Ven C; Ayello J; Militano O; Miller LL; Krailo M; Reaman G; Cairo MS;
    Clin Cancer Res; 2005 Apr; 11(7):2644-50. PubMed ID: 15814645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura.
    Hua B; Zou N; Wang S; Zhu T; Zhao Y
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):291-5. PubMed ID: 15870550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].
    Zhang ML; Chen WS; Han B
    Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):637-642. PubMed ID: 32942816
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.
    Wang H; Dong Q; Fu R; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Shao Z
    Biomed Res Int; 2015; 2015():597293. PubMed ID: 25861635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
    Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
    Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of recombinant human thrombopoietin combined with glucocorticoids in the treatment of immune thrombocytopenia.
    Zhou JX; Gao L; Hu N; Yan ZL; Tian CY; Su J; Qi JJ; Yue JS; Ma WT
    Hematology; 2022 Dec; 27(1):1062-1068. PubMed ID: 36094428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
    Wang Y; Wang Z; Wu L; Zhang J; Wang J; Yan L
    Ann Hematol; 2013 Dec; 92(12):1695-9. PubMed ID: 23778995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
    Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
    BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
    Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
    World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia.
    Yu Y; Hou Y; Zhao Y; Zhou H; Jing F; Liu Y; Peng J; Liu X; Hou M
    Br J Haematol; 2021 Jul; 194(1):191-194. PubMed ID: 33993469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation.
    Sun YQ; Kong Y; Zhang XH; Wang Y; Shi MM; Song Y; Kong J; Fu HX; Yan CH; Xu LP; Liu KY; Huang XJ
    Platelets; 2019; 30(8):994-1000. PubMed ID: 30569802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of low-dose rituximab in combination with recombinant human thrombopoietin in treating ITP.
    Li Y; Wang YY; Fei HR; Wang L; Yuan CL
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1583-8. PubMed ID: 26004596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.